GLOBUS MEDICAL INC
GMEDOther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958.1M | $789.0M |
| Operating income | $479.8M | $166.0M | $133.1M | $228.0M | $172.0M | $111.4M |
| Net income | $537.9M | $103.0M | $122.9M | $190.2M | $149.2M | $102.3M |
| Total assets | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B |
| Total liabilities | $729.5M | $1.07B | $1.09B | $229.8M | $215.9M | $173.2M |
| Equity | $4.57B | $4.18B | $4.00B | $1.85B | $1.74B | $1.51B |
| EPS (diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 |
| Shares out. | 137.5M | 135.4M | 100.3M | 101.6M | 99.8M | 101.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 16.3%
- Net margin
- 18.3%
- Return on equity
- 11.8%
- Return on assets
- 10.1%
- Return on capital (ROCE)
- 10.0%
- Liabilities / assets
- 13.8%
- Debt / equity
- 0.16×
- Book value / share
- $33.25
- Revenue growth (YoY)
- 16.7%
- Net income growth (YoY)
- 422.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 10.06safe
- Accruals / assets
- −4.1%clean
- Beneish M-Score
- -2.44normal
- Piotroski F-Score
- 8/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 6 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 1, 2017
- NT 10-Kmissed a reporting deadline ↗Mar 3, 2014
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Capital Management LlcPassive (13G)Apr 30, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Janus Henderson Group PlcPassive (13G)May 14, 2025
- Blackrock, Inc.Passive (13G)Apr 24, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Huller KellyOfficer — EVP, GC, Corporate Secretary | Feb 25, 2026 | Option exercise | 20,000 | $43.58 |
| Huller KellyOfficer — EVP, GC, Corporate Secretary | Feb 12, 2026 | Option exercise | 10,000 | $45.64 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.4M | 1.6 | +9.4% |
| Apr 30, 2026 | 3.1M | 3.5 | -5.8% |
| Apr 15, 2026 | 3.3M | 2.9 | +17.1% |
| Mar 31, 2026 | 2.8M | 2.9 | -14.1% |
| Mar 13, 2026 | 3.3M | 3.3 | +0.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 7, 2026
- Director / officer change · Regulation FD disclosureMar 23, 2026
- Results of operationsFeb 24, 2026
- Results of operationsJan 7, 2026
- Results of operationsNov 6, 2025
- Results of operationsAug 7, 2025
- Results of operations · Director / officer change · Regulation FD disclosureJul 21, 2025
- Director / officer change · Shareholder voteJun 5, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.